QUANTUM DOT CORP. TO COLLABORATE WITH GENENTECH
PROGRESS IS SWIFT AT Quantum Dot Corporation, based in Palo Alto, California. Quantum Dot announced an agreement to collaborate with Genentech, Inc., headquartered in San Francisco, California. The goal is to evalute Qdot™ nanocrystals in a number of Genentech’s biological research assays.
Quantum Dot also raised another $30 million in private venture capital last month. Qdot nanocrystals are nanometer-sized semiconductor crystals which light up like molecular-sized LEDs and can be used like fluorescent markers in bioassays.
Qdot nanocrystals can be used to create multiplexed bioassays. Quantum Dot Corporation has its eye on the diagnostics marketplace. “We’ve already signed a deal with one of the five largest diagnostics companies,” said Sangita Parikh, Marketing Manager at Quantum Dot. “We expect to complete one more partnership agreement involving diagnostics by year’s end.”
Qdot nanocrystals are an emerging technology that can be used to create multiplexed bioassays which have increased accuracy and lower cost. Quantum Dot Corporation wants to develop its technology through partnerships with selected companies.
HEALTHEON/WEBMD LOOSES SOME LUSTER WITH WALL STREET
AFTER A BLISTERING YEAR OF BIG acquisitions and lots of publicity, Healtheon/WebMD’s first quarter earnings proved disappointing to investors. Although revenue increased from $17.6 million to $65.9 million over the same quarter last year, Healtheon/WebMD’s net loss soared.
The company lost $431 million in the first quarter, compared to only $18.6 million for Q1 in 1999. On the positive side, there was steady growth in key services offered by the healthcare E-commerce firm.
Healtheon/WebMD says that 100,000 physicians are now registered users of WebMD Practice. This is a 47% jump from the 68,000 registered physician users in fourth quarter of 1999. It said transactions were 131 million for first quarter, of which 4.8 million were Internet transactions.
Healtheon/WebMD is working to install its Web browser-based laboratory test ordering/reporting product in several laboratories. Laboratory Corporation of America, DIANON Systems, and UroCor have contracted to use the Healtheon/WebMD lab solution.
TELEPATHOLOGY MOVES AHEAD WITH ILLUMEA
ONE COMPANY THAT’S ATTRACTING plenty of attention from the pathology profession is Illumea Corporation, based in Newport Beach, California.
Illumea’s telepathology system will be used by DIANON Systems, Inc. to link its headquarters laboratory in Stratford, Connecticut with the DIANON laboratory in Tampa Bay, Florida. It will be used for intracompany teleconsultations. Illumea was also recently selected as a preferred vendor by Pathology Service Associates, headquartered in Florence, South Carolina.